CoreCap Advisors’s Zimmer Biomet ZBH Stock Holding History

CoreCap Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.8K	Buy	358 +14	+4%	+$1.23K	﹤0.01%	1626
2026 Q1	$31.1K	Buy	344 +1	+0.3%	+$92	﹤0.01%	1506
2025 Q4	$30.8K	Buy	343 +19	+6%	+$1.8K	﹤0.01%	1511
2025 Q3	$31.9K	Sell	324 -13	-4%	-$1.29K	﹤0.01%	1491
2025 Q2	$30.7K	Sell	337 -39	-10%	-$3.77K	﹤0.01%	1448
2025 Q1	$42.6K	Sell	376 -34	-8%	-$3.64K	﹤0.01%	1246
2024 Q4	$43.3K	Buy	410 +82	+25%	+$8.8K	﹤0.01%	1248
2024 Q3	$35.4K	Sell	328 -18	-5%	-$1.96K	﹤0.01%	1333
2024 Q2	$37.6K	Sell	346 -12	-3%	-$1.42K	﹤0.01%	731
2024 Q1	$47.2K	Buy	+358	New	+$44.7K	﹤0.01%	1138
2022 Q4	$44.4K	Buy	+348	New	+$40.4K	﹤0.01%	1030
2022 Q3	–	Sell	-34	Closed	-$4K	–	2154
2022 Q2	$4K	Buy	+34	New	+$4.03K	﹤0.01%	1752
2022 Q1	–	Sell	-35	Closed	-$4K	–	2154
2021 Q4	$4K	Buy	+35	New	+$4.58K	﹤0.01%	1835

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CoreCap Advisors's ZBH Position: Q2 2026 in Review

CoreCap Advisors increased its Zimmer Biomet (ZBH) stake by 4.1% in Q2 2026, buying an estimated $1.23K and bringing the position to 358 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

CoreCap Advisors first reported a position in ZBH in Q4 2021 and has held it in 13 quarters since. The position peaked at $47.2K in Q1 2024. 120 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

CoreCap Advisors held 358 shares of Zimmer Biomet worth $30.8K as of Q2 2026.
CoreCap Advisors bought 14 Zimmer Biomet shares in Q2 2026, an estimated $1.23K.
Zimmer Biomet made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1626 holding.
CoreCap Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's Zimmer Biomet position peaked at $47.2K in Q1 2024.
120 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.